Mar 02, 2016
Hologic has appointed Chris Coughlin to its board of directors. He currently serves on the boards of Allergan (formerly Actavis), Alexion Pharmaceuticals, and Dun & Bradstreet, where he is chairman of the board. Coughlin has held executive operating and financial positions at the Interpublic Group, Pharmacia, and Nabisco International. He previously served on the boards of Covidien, Dipexium Pharmaceuticals, Forest Laboratories, the Interpublic Group, Monsanto, and Perrigo.